“We found that some of the quick single-use kits (LFIAs) are as accurate as our sophisticated laboratory technologies,” co-author of the study Jonathan Edgeworth said.
“Encouraged by these findings we are piloting LFIAs in the hospital to give doctors a quick reliable answer in a range of clinical settings.”
The blood is thought to contain antibodies which can help fight COVID-19. Photo: Red Cross Lifeblood
At least 14 different antibody tests have been approved by the Therapeutic Goods Administration for legal supply in Australia, giving medical professionals the ability to monitor the coronavirus in patients.
The TGA prohibits the supply of self-tests for COVID-19 and last week noted on its website that it was not yet evident whether the presence of antibodies meant someone was immune to the virus.
And the detection of antibodies may not mean an infected person has recovered from the virus, it said on its website.
There is also the question of how long do the antibodies last.
England’s chief medical officer, Professor Chris Witty, this week revealed in a press conference that there were indications the antibodies can “fade” in some people who have recovered from the coronavirus.
However, the UK National Health Service said antibody tests are to “help the NHS and scientists learn more about who has already had the virus and how it has spread in the UK”.